Medicare Enrolled
Dr. Mark Peterman, MD
Cardiovascular Disease · Plano, TX
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Peterman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peterman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peterman
Dr. Mark Peterman is a cardiovascular disease in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Peterman performed 4,434 Medicare services across 3,203 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peterman received a total of $22,492 from 68 pharmaceutical and/or device companies across 886 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peterman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 21% volume in TX$ $22,492 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,434
Medicare services
Top 21% in TX for cardiovascular disease
3,203
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~233 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 722 | $90 | $220 |
| Electrocardiogram (EKG), 12-lead | 713 | $10 | $47 |
| EKG interpretation and report | 440 | $6 | $40 |
| Hospital follow-up visit, moderate complexity | 389 | $60 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test | 324 | $43 | $150 |
| Echocardiogram, transthoracic | 286 | $139 | $800 |
| Initial hospital admission, moderate complexity | 164 | $90 | $280 |
| New patient office visit (45-59 min) | 110 | $111 | $335 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 101 | $19 | $135 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 101 | $28 | $150 |
| Heart muscle strain imaging | 100 | $29 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 81 | $49 | $190 |
| Hospital follow-up visit, high complexity | 76 | $85 | $236 |
| Remote pacemaker/defibrillator monitoring, 90 days | 75 | $16 | $70 |
| Remote pacemaker monitoring, 90 days | 72 | $22 | $135 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 72 | $36 | $394 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 70 | $340 | $2,500 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 66 | $165 | $800 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 64 | $49 | $370 |
| Ultrasound of heart blood flow, valves and chambers | 64 | $39 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 64 | $18 | $190 |
| Ultrasound of both sides of head and neck blood flow | 56 | $140 | $510 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $10 | $25 |
| Cardiac catheterization | 31 | $187 | $967 |
| Coronary stent placement | 27 | $396 | $3,000 |
| Hospital follow-up visit, low complexity | 25 | $39 | $80 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $78 | $275 |
| Programming of dual lead pacemaker system | 18 | $43 | $105 |
| Ct scan of blood vessels and grafts of heart with contrast | 13 | $89 | $245 |
| External shock to heart to regulate heart beat | 13 | $75 | $420 |
| Office visit, established patient, complex (40-54 min) | 13 | $140 | $295 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $17 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $11 | $141 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.4% high complexity
17.0% medium
68.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,492
Total received (2018-2024)
Avg $3,213/year across 7 years
Top 18% in TX for cardiovascular disease
68
Companies
886
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,444 (99.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$49 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,599
2023$2,352
2022$3,578
2021$3,015
2020$2,143
2019$3,066
2018$4,738
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$2,369
Janssen Pharmaceuticals, Inc
$2,002
Medtronic Vascular, Inc.
$1,901
Amgen Inc.
$1,379
HEARTFLOW, INC.
$1,242
Novartis Pharmaceuticals Corporation
$1,235
PFIZER INC.
$839
HeartFlow, Inc.
$777
GENZYME CORPORATION
$757
E.R. Squibb & Sons, L.L.C.
$578
AstraZeneca Pharmaceuticals LP
$575
Medtronic, Inc.
$550
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$550
Amarin Pharma Inc.
$512
Merck Sharp & Dohme LLC
$470
Alnylam Pharmaceuticals Inc.
$467
Boehringer Ingelheim Pharmaceuticals, Inc.
$462
Medicure Pharma Inc.
$457
SANOFI-AVENTIS U.S. LLC
$428
Lundbeck LLC
$410
Itamar Medical Inc
$367
Regeneron Healthcare Solutions, Inc.
$358
Esperion Therapeutics, Inc.
$342
Boston Scientific Corporation
$332
ABIOMED
$302
Cleerly, Inc.
$255
Chiesi USA, Inc.
$215
Gilead Sciences, Inc.
$165
ARBOR PHARMACEUTICALS, INC.
$159
Merck Sharp & Dohme Corporation
$142
Astellas Pharma US Inc
$137
Kowa Pharmaceuticals America, Inc.
$136
Recor Medical Inc
$131
SCPHARMACEUTICALS INC.
$120
Imperative Care, Inc
$120
BOSTON SCIENTIFIC CORPORATION
$120
AngioDynamics, Inc.
$79
Kiniksa Pharmaceuticals International, plc
$78
W. L. Gore & Associates, Inc.
$78
Innovation Technologies Inc
$72
Cardiac Assist, Inc.
$72
Althera Pharmaceuticals LLC
$69
BARD PERIPHERAL VASCULAR, INC.
$65
Tactile Systems Technology Inc
$61
CHIESI USA, INC.
$54
CVRx, Inc.
$53
Arbor Pharmaceuticals, Inc.
$53
Baxter Healthcare
$40
G Medical Diagnostic Services, Inc.
$28
Edwards Lifesciences Corporation
$26
ACIST MEDICAL SYSTEMS, INC.
$24
Philips Electronics North America Corporation
$24
Lexicon Pharmaceuticals, Inc.
$23
ATRICURE, INC.
$20
Inari Medical, Inc.
$19
Novo Nordisk Inc
$19
Azurity Pharmaceuticals, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$17
Inspire Medical Systems, Inc.
$15
Preventice Services, LLC
$15
Saranas, Inc.
$15
iRhythm Technologies, Inc.
$15
Allergan Inc.
$14
Surmodics, Inc.
$14
Bardy Diagnostics, Inc.
$14
Shockwave Medical, Inc
$14
Intact Vascular, Inc.
$14
CORDIS US CORP.
$13
Top 3 companies account for 27.9% of total payments
Associated products mentioned in payments ›
(8334) IGT D Peripheral · ALPHAVAC · AMPLATZER TALISMAN · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · Abre · Aggrastat (tirofiban HCl) · Agilis NxT EP Introducer · Arcalyst · Asahi Fielder coronary guide wire · BG Mini Plus · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Cleerly Ischemia · Confirm Rx · CoreValve Evolut · Corlanor · EDARBYCLOR · ELIQUIS · ELUVIA · ENSITE · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Ensite Cardiac Mapping System · FABRAZYME · FABRY-DISEASE · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GORE CARDIOFORM Septal Occluder · HMG-CoA reductase inhibitor. · Hillrom - Carnation Ambulatory Monitor · INSPIRE · IRRISEPT · Impella · Inpefa · Intracardiac Echocardiography (ICE) · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LUTONIX · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROMUS · Pounce Venous Thrombectomy System · Quadra Assura CRT Defibrillator · RXI SYSTEMS · Repatha · Resolute · Roszet · S.M.A.R.T. CONTROL · SYNERGY · SYNERGY ABLATION SYSTEM · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Tack Endovascular System · TandemHeart · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaSeal · WATCHMAN · WatchPAT · WatchPATONE · XARELTO · XIENCE SKYPOINT · Xience Sierra Coronary Stent System · ZIO Patch · ZOOM 88-T LARGE DISTAL PLATFORM · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $507 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
290
Per 100K population
26.0
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Peterman is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 21% in TX), and high industry engagement (low-engagement, top 18%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Peterman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Peterman performed 722 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peterman receive payments from pharmaceutical companies?
Yes. Dr. Peterman received a total of $22,492 from 68 companies across 886 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peterman's costs compare to other cardiovascular diseases in Plano?
Dr. Peterman's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peterman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Plano
Browse cardiovascular diseases in Plano ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology